H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.1% of adults in Charlotte have diagnosed diabetes — 1.9 points below the U.S. 12% figure. Census population 897,720. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Charlotte clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Charlotte storefront.
Platelet Rich Plasma (PRP) Therapy in Charlotte, NC for clinics & physicians. PRP therapy systems with 1-m… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Charlotte is 30.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 10.1% of adults in Charlotte have diagnosed diabetes — 1.9 points below the U.S. 12% figure. North Carolina includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for platelet rich plasma therapy, not a walk-in clinic.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)JM reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Charlotte is 10.1% or not. PLACES is planning data. The LCD is the claim.
If you already buy platelet rich plasma therapy elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 10.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 10.1% of adults — 1.9 points below the U.S. 12% figure. Obesity is 30.1%; arthritis is 20.9%. That is place-level BRFSS modeling, not a clinic census and not a Charlotte trial.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). N.C. Department of Health & Human Services is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including North Carolina.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Charlotte.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Charlotte tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Charlotte, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Charlotte is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Charlotte — 1.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Charlotte. Useful for joint-program math; still needs a diagnosis and privileging.
No Charlotte storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.